test.
Method -Twenty two patients diagnosed as having LG between 1984 and 1994 were investigated by upper gastrointestinal endoscopy at which gastric and duodenal biopsy specimens were taken for histological assessment and immunohistology. Serum was collected for measurement of anti-H pylon, anti-gliadin and anti-endomysial antibodies. A lactuloselmannitol absorption test was performed within one week of endoscopy. Control groups were studied by histology, serology and permeability tests. Results -Three patients had been recently diagnosed as having LG while 15 still had the condition after a mean of 13-9 (range two to 38) months.
LG involved the antrum alone in three patients, antrum and body in seven, body alone in six, and gastric remnant in two. Gastroduodenal intraepithelial lymphocytes (IELs) were T cells and predominantly of T suppressor (CD8) type. Duodenal IELs were increased compared to agelsex matched controls with chronic gastritis. Four patients had duodenal villous atrophy. Four patients no longer had LG after a mean of 29*3 (10- Lymphocytic gastritis is the histological counterpart of the macroscopic entity, varioliform gastritis.'2 It is found in approximately 1% of gastric biopsy specimens from dyspeptic patients" and is characterised by an accumulation of lymphocytes in the surface and foveolar epithelium (fig 1) .' 2The normal stomach is devoid of intraepithelial lymphocytes (IELs) while in Helicobacter pyloni associated chronic gastritis between four and seven lymphocytes per 100 epithelial cells are found.'2 The diagnostic threshold for lymphocytic gastritis is usually taken as greater than 25 IELs per 100 cells.'24 Endoscopically, there are enlarged rugal folds bearing nodular erosions principally involving the body of the stomach though in some cases of histological lymphocystic gastritis the endoscopic appearances may be normal. ' 2 4 Little is known of the aetiology or natural history of lymphocytic gastritis. It has been attributed to an atypical response to H pylori infection.2 However, while many patients are seropositive to the micro-organism, its presence is not usually confirmed histologically.2 It has also been suggested that lymphocytic gastritis may be a manifestation of coeliac disease. In one study of body, 6% (3-3-8) (p<0-001)). Adequate biopsy specimens from both anundergoing routine diagnostic endoscopy, and trum and corpus were available from the initial found to have chronic gastritis (with or without diagnostic endoscopy in only 11 patients for H pylori infection), were used as controls.
comparison with the follow up biopsy specimens. Gastric IELs were counted in these paired biopsy specimens ( Figure 3 Duodenal (second part) biopsy specimens from a patient with lymphocytic gastritis and villous atrophy before (left) and after (right) three months of treatment with a gluten free diet.
Lymphocytic gastris and small bowel disease numbers for a diagnosis of lymphocytic gastritis, they are higher than in controls. We also confirm that lymphocytic gastritis varies in its endoscopic appearance.'24 It can take on the classic diffuse varioliform gastritis picture or the antral folds alone may appear red and thickened. In a minority of patients the endoscopic appearances may be normal. In this study four patients with lymphocytic gastritis had severe villous atrophy consistent with coeliac disease. We have also found that patients with lymphocytic gastritis and normal villous architecture have increased IEL numbers in their duodenal mucosa. While an increased prevalence of lymphocytic gastritis has been reported in coeliac disease,6 a previous study of patients with lymphocytic gastritis did not detect any small bowel abnormality on standard histological examination.4 Increased small intestinal IEL counts are present in patients with treated coeliac disease following gluten challenge,'2 dermatitis herpetiformis,'3 first degree relatives of patients with coeliac disease,'4 and those with low grade small intestinal enteropathy.'5 The finding of increased IEL numbers in the duodenal mucosa and, in two cases, the beneficial effects of gluten withdrawal, lend some support to the hypothesis that lymphocytic gastritis is another manifestation of a gluten related enteropathy.
The finding of abnormal small intestinal permeability in patients with current and previous lymphocytic gastritis without histological evidence of villous atrophy is of interest. Only one patient (case 16) was taking non-steroidal antiinflammatory drugs and his permeability test was normnal. Our results suggest that lymphocytic gastritis per se is associated with impaired small bowel function. This finding should prompt a re-appraisal of the reported link between lymphocytic gastritis and a protein losing gastropathy which was first recognised by Crampton et in apparently healthy and first degree relatives of patients with coeliac disease. Differing degrees of sensitivity to gluten are believed to account for the geographical variation in the incidence of coeliac disease and the spectrum of histological changes from complete villous atrophy to normal jejunal mucosa.923-27 Inappropriate immune reactions to gliadin occur in the mouth28 and the rectum29 and recently an association between lymphocytic colitis and coeliac disease has been described.30 Therefore gastric mucosal involvement is not unexpected. Coeliac disease is associated with an increased incidence of gastritis and abnormal gastric function which has previously been attributed to an autoimmune gastritis.3-33 However, the incidence of autoimmune gastritis has been found to be low in coeliac disease34 whereas gastric mucosal IEL numbers are increased.635 Co-existent lymphocytic gastritis may account, in part, for these abnormalities. Using serology, we have found no difference in the prevalence of H pylori antibodies in patients with lymphocytic gastritis compared with dyspeptic controls. The relatively low prevalence of the organism on histology4 when compared with the usual chronic (type B) gastritis, and the discrepancy between the histological and serological Hpylori status in patients with lymphocytic gastritis is consistent with a previous study.2 However, a negative histological result might not necessarily mean that infection is absent. False negative results could be explained by inadequacies in techniquethat is, the bacteria could be present in very small numbers and not recognised in the sections. Alternatively, they may have adopted the coccoid form in response to the hostile environment brought about by the mucosal inflammatory response. Sensitive methods of detection such as in situ hybridisation or a polymerase chain reaction technique would clarify this point. While it is possible that lymphocytic gastritis is a manifestation of an effective, but unusual, host immune response to H pylori, it may be completely unrelated to infection. It is certainly apparent that in most cases the process persists in an active form in the absence of Hpylori infection. However, an alternative explanation is that Hpylori infection triggers an immunopathological process in the gastric mucosa of predisposed individuals, possibly by the enhanced expression of class II HLA,36 in much the same way as latent gluten enteropathy could be unmasked by intestinal infection and lead to its presentation as overt adult onset coeliac disease. 27 In conclusion, we have found that gastric mucosal IELs remain persistently elevated in subjects with lymphocytic gastritis, refuting previous suggestions that the disease is transient. The finding of duodenal villous atrophy in four patients, and the presence of increased duodenal IEL numbers and abnormal small intestinal permeability in other patients, leads one to speculate that lymphocytic gastritis represents part of a diffuse lymphocytic gastroenteropathy which varies in its expression from site to site. Thus, coeliac disease represents a primary small intestinal disorder which is accompanied by intraepithelial lymphocytosis in the stomach, while lymphocytic gastritis is primarily a gastric disorder accompanied by intraepithelial lymphocytosis and functional disturbances in the small intestine. On rare occasions, coeliac disease and fully developed (varioliform) lymphyocytic gastritis co-exist. Whether these two conditions represent abnormal immune reactions to a common antigen related to gluten or to totally different antigens awaits further investigation. Likewise, the relation of lymphocytosis in the large intestine to coeliac disease and lymphocytic gastritis requires further study. It is possible that lymphocytic colitis is another manifestation of a mucosal immune response to luminal antigen, which in this instance is maximally expressed in the large intestine. A comparison of HLA status and the antigen responsiveness of gastrointestinal lymphocytes in patients with lymphocytic gastritis, lymphocytic colitis and coeliac disease would add greatly to our understanding of the inter-relations between these intriguing conditions. 
